L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model.
作者信息
Liu Yiwei, Janke Laura J, Li Lie, Relling Mary V
机构信息
a Department of Pharmaceutical Sciences , St. Jude Children's Research Hospital , Memphis , TN , USA.
b Department of Pathology , St. Jude Children's Research Hospital , Memphis , TN , USA.
出版信息
Leuk Lymphoma. 2019 Aug;60(8):2088-2090. doi: 10.1080/10428194.2019.1571198. Epub 2019 Feb 4.
Abstract
摘要
相似文献
1
L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model.
Leuk Lymphoma. 2019 Aug;60(8):2088-2090. doi: 10.1080/10428194.2019.1571198. Epub 2019 Feb 4.
2
Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature.
J Oncol Pharm Pract. 2018 Jul;24(5):393-397. doi: 10.1177/1078155217710714. Epub 2017 May 19.
3
Levocarnitine supplementation for asparaginase-induced hepatotoxicity in adult acute lymphoblastic leukemia patients: A multicenter observational study of the campus all group.
Leuk Res. 2022 Nov;122:106963. doi: 10.1016/j.leukres.2022.106963. Epub 2022 Sep 21.
4
Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors.
Leuk Lymphoma. 2014 Jul;55(7):1670-4. doi: 10.3109/10428194.2013.845886. Epub 2013 Nov 14.
5
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
Cancer Med. 2021 Nov;10(21):7551-7560. doi: 10.1002/cam4.4281. Epub 2021 Sep 16.
6
Levocarnitine for pegasparaginase-induced hepatotoxicity in acute lymphoblastic leukemia.
Leuk Lymphoma. 2020 Dec;61(13):3161-3164. doi: 10.1080/10428194.2020.1805108. Epub 2020 Aug 13.
7
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature.
Leuk Lymphoma. 2018 Oct;59(10):2360-2368. doi: 10.1080/10428194.2018.1435873. Epub 2018 Feb 12.
8
An experience with plasma exchange treatment of acute lymphoblastic leukemia in a case with fulminant hepatitis related to L-asparaginase.
Transfus Apher Sci. 2013 Oct;49(2):328-30. doi: 10.1016/j.transci.2013.06.010. Epub 2013 Jul 16.
9
Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.
Pharmacogenomics J. 2017 Jun;17(3):274-279. doi: 10.1038/tpj.2016.7. Epub 2016 Mar 29.
10
Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
J Oncol Pharm Pract. 2018 Jun;24(4):299-308. doi: 10.1177/1078155217701291. Epub 2017 Mar 29.
引用本文的文献
1
Effects of asparaginases and L-carnitine on Western-diet-induced hepatosteatosis in mice.
F1000Res. 2022 Feb 1;11:128. doi: 10.12688/f1000research.75870.1. eCollection 2022.
2
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic Leukemia.
JAMA Netw Open. 2022 Dec 1;5(12):e2248803. doi: 10.1001/jamanetworkopen.2022.48803.
3
Mechanistic studies of PEG-asparaginase-induced liver injury and hepatic steatosis in mice.
Acta Pharm Sin B. 2021 Dec;11(12):3779-3790. doi: 10.1016/j.apsb.2021.11.022. Epub 2021 Dec 4.
4
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia.
Cancer Med. 2021 Nov;10(21):7551-7560. doi: 10.1002/cam4.4281. Epub 2021 Sep 16.
5
Pharmacogenomics and ALL treatment: How to optimize therapy.
Semin Hematol. 2020 Jul;57(3):130-136. doi: 10.1053/j.seminhematol.2020.10.001. Epub 2020 Oct 20.
6
Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia.
Leuk Lymphoma. 2020 Feb;61(2):420-428. doi: 10.1080/10428194.2019.1666379. Epub 2019 Sep 16.
本文引用的文献
1
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature.
Leuk Lymphoma. 2018 Oct;59(10):2360-2368. doi: 10.1080/10428194.2018.1435873. Epub 2018 Feb 12.
2
Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature.
J Oncol Pharm Pract. 2018 Jul;24(5):393-397. doi: 10.1177/1078155217710714. Epub 2017 May 19.
3
Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
J Oncol Pharm Pract. 2018 Jun;24(4):299-308. doi: 10.1177/1078155217701291. Epub 2017 Mar 29.
4
Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.
Clin Pharmacol Ther. 2017 Jul;102(1):131-140. doi: 10.1002/cpt.629. Epub 2017 Apr 4.
5
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial.
Leukemia. 2017 Jan;31(1):58-64. doi: 10.1038/leu.2016.219. Epub 2016 Aug 2.
6
Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.
Pharmacogenomics J. 2017 Jun;17(3):274-279. doi: 10.1038/tpj.2016.7. Epub 2016 Mar 29.
7
L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity.
Acta Haematol. 2016;135(4):208-10. doi: 10.1159/000442342. Epub 2016 Feb 4.
8
Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine.
Proc (Bayl Univ Med Cent). 2016 Jan;29(1):46-7. doi: 10.1080/08998280.2016.11929355.
9
Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Eur J Haematol. 2016 Feb;96(2):160-9. doi: 10.1111/ejh.12562. Epub 2015 Apr 24.
10
Investigation of protective effect of L-carnitine on L-asparaginase-induced acute pancreatic injury in male Balb/c mice.
Dig Dis Sci. 2015 May;60(5):1290-6. doi: 10.1007/s10620-014-3461-3. Epub 2014 Dec 14.
Zotero 插件